1Monto A,Moutl A,Sharp S.Effect of zanamivir on duration and resolution of influenza symptoms[J].Clin.Ther,2000,22:1294-1305. 被引量：1
2Wareing M,Tannock G.Live attenuated vaccines against influenza; an historical review[J].Vaccine,2001,19:3320 -3330. 被引量：1
3Nichol K.Live attenuated influenza virus vaccines:new options for the prevention of influenza[J].Vaccine,2001,19:4373-4377. 被引量：1
4Parkin N,Chiu P,Coelingh K.Genetically engineered live attenuated influenza A virus vaccine candidates[J].J.Virol,1997,71:2772-2778. 被引量：1
5Watanabe T,Watanabe S,Neumann G,et al.Immunogenicity and protective efficacy of replication-incompetent influenza virus-like particles[J].J.Virol,2002,76:767-773. 被引量：1
6Kodihalli S,Kobasa D,Webster R.Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines[J].Vaccine,2000,18:2592-2599. 被引量：1
7Glueck R.Review of intranasal influenza vaccine[J].Adv.Drug Deliv.Rev,2001,51:203-211. 被引量：1
8Illum L,Jabbal-Gill I,Hinchcliffe M,et al.Chitosan as a novel nasal delivery system for vaccines[J].Adv.Drug Deliv.Rev,2001,51:81-96. 被引量：1
9Bush R,Bender C,Subbarao K,et al.Predicting the evolution of human influenza A[J].Science,1999,286:1866-1867. 被引量：1
10Hoffmann E,Krauss S,Perez D,et al.Eight-plasmid system for rapid generation of influenza virus vaccines[J].Vaccine,2002,20:3165-3170. 被引量：1
